Shema R, Kulicke R, Cowley GS, Stein R, Root DE, Heiman M. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington’s disease. Proc Natl Acad Sci U S A. 2015;112(1):268-72. doi:10.1073/pnas.1417231112
Carroll JB, Deik A, Fossale E, et al. HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation. PLoS One. 2015;10(8):e0134465. doi:10.1371/journal.pone.0134465
Lee JM, Kim KH, Shin A, et al. Sequence-Level Analysis of the Major European Huntington Disease Haplotype. Am J Hum Genet. 2015;97(3):435-44. doi:10.1016/j.ajhg.2015.07.017
Keum JW, Shin A, Gillis T, et al. The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease. Am J Hum Genet. 2016;98(2):287-98. doi:10.1016/j.ajhg.2015.12.018
Correia K, Harold D, Kim KH, et al. The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington’s Disease. J Huntingtons Dis. 2015;4(3):279-84. doi:10.3233/JHD-150169